What to Expect from Your Mounjaro First Dose

Why 2.5 mg specifically (and what the trial data show about the starting dose

Eli Lilly's SURMOUNT-1 trial) published in the New England Journal of Medicine and involving 2,539 adults with obesity, tested tirzepatide at 5 mg, 10 mg and 15 mg maintenance doses after a structured lead-in period. Participants began at 2.5 mg for the first four weeks in every arm. Average weight loss at 15 mg reached around 20–21% of body weight by 72 weeks; the point is that nobody arrived there without first spending time at 2.5 mg. The starting dose exists to let the gut adapt to slower gastric emptying and altered hormonal signalling, not to produce a dramatic effect in week one. Expecting significant appetite suppression from the first dose of tirzepatide can lead to unnecessary disappointment, or, worse, to people assuming the medicine is not working when the titration process is simply doing its job.

The NHS tirzepatide patient page confirms that treatment starts at 2.5 mg and is typically increased in 2.5 mg steps every four weeks, guided by how well each dose is tolerated. Six strengths are available in total: 2.5, 5, 7.5, 10, 12.5 and 15 mg, and you can read about what the increase involves on our Mounjaro 5mg page.

What most people actually feel after their first Mounjaro injection

The most commonly reported experiences in the first week are gastrointestinal: nausea is the headline one, followed by constipation, indigestion and, less often, vomiting or loose stools. Fatigue and mild headache also appear in the early-use data. These reactions are not a sign that something has gone wrong, they reflect the medicine slowing the movement of food through your stomach, which is part of how it works. For most people the intensity peaks within the first day or two after injecting and then settles, often noticeably so by the second or third week at 2.5 mg. Eating smaller portions, avoiding very fatty meals and staying well hydrated all help. Some people find injecting at bedtime means any nausea passes during sleep, though the right time for your routine is something to discuss with your prescriber, there is practical detail on timing your first Mounjaro dose that is worth reading before you start.

If your first dose produces no noticeable effect at all (no change in appetite, no GI symptoms) that is also normal. Read more about what to do if your first Mounjaro dose has no effect; it does not mean the medicine is not working for you.

Practical steps for injection day, and the weeks that follow

Mounjaro is injected subcutaneously once a week, into the abdomen, thigh or upper arm; rotate sites each time. The pen should be stored in the fridge between 2–8°C and brought to room temperature before use, for exact handling windows, the SmPC on the eMC is the definitive reference, not general advice online. Choose the same day each week if you can; consistency makes it easier to keep track. One thing worth planning around: if your first pen arrives on a Friday and you inject that evening, your second injection falls the following Friday, useful to know if you have holidays or a bank holiday Monday order coming up, since delivery schedules can shift.

After the first four weeks at 2.5 mg, your prescriber will review whether to increase to 5 mg. For context on what that step involves, the first week at 5 mg often feels similar to week one at 2.5 mg, another short adjustment period before the body settles. The full process is described in the step-by-step guide to taking your first Mounjaro dose if you want practical detail before injecting.

Who starts at 2.5 mg and what eligibility looks like in practice

The 2.5 mg starting dose applies to everyone, regardless of body weight, because it is a pharmacological choice, not a weight-based calculation. Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above when a weight-related condition (such as hypertension, prediabetes or obstructive sleep apnoea) is also present. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. Whether those criteria apply to you is a clinical question, not a self-assessment: a prescriber reviews your full picture, including any medicines you currently take, before approving treatment. If you are considering what weight management treatment might suit your situation, the treatment overview sets out the licensed options clearly. When you are ready to take the next step, check your eligibility with our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.